PIPELINE

Renal Cancer

Development Stage	Early Development
U.S. Incidence of Renal Cancer¹	40,000/Year

About Renal Cancer and Genomic Health’s Products in Development

Renal, or kidney, cancer is diagnosed when cancerous growths are found in a person’s kidneys. In adults, the most common type of renal cancer is known as renal cell carcinoma. Renal cancer is often detected when people are undergoing procedures for other diseases. The incidence of renal cancer seems to be increasing although the reason is not well understood. People who smoke are at increased risk for this type of cancer, and genetics may also play a factor. Surgery is currently the standard treatment. A test which would provide insight into the individual biology and behavior of newly diagnosed renal cancers is greatly needed in order to facilitate treatment decisions. Genomic Health is working to develop such tests.

For more information about renal cancer, visit the National Cancer Institute’s Kidney Cancer page or the nonprofit group Kidney Cancer Association’s website at www.kidneycancer.org.